Alpha hand coherence analysis of EEG in healthy adult and Alzheimer's type dementia subjects;Estudo da coerência do eletrencefalograma para a banda de frequência alfA em indivíduos adultos normais e com provável demência do tipo Alzheimer

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 2 A, 2000, Pages 272-275

  Anghinah, Renato ^a   Kanda, Paulo Afonso Medeiros ^a   Jorge, Mário Silva ^a   De Lima, Edson Erasmo Pereira ^a   Pascuzzi, Luiz ^a   De Melo, Antônio Carlos Paiva ^a  

^a NONE

Author keywords

Coherence analysis; Dementia; Quantitative electroencephalography

Indexed keywords

ALPHA RHYTHM; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; EVALUATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ALPHA RHYTHM; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0034201390     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2000000200011     Document Type: Article

References (15)

1. Bruni J. Phenytoin toxicity. In Levy RH Meldrum BS (eds). Antiepileptic drugs. Ed.4, New York: Raven Press, 1995:345-350.
2. Kuruvilla T, Bharucha NE. Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 1997; 38: 500-502.
3. Botez M I, Altig E, Vezina JL. Cerebellar atrophy in epileptic patients. Can J Neurol Sci 1988;15:299-303.
4. Rapport RL, Shaw CM. Phenytoin-related cerebellar degeneration without seizures. Ann Neurol 1977;2:437-439.
5. Selhorst JB, Kaufman B, Horowitz SJ. Diphenylhydantoin-induced cerebellar degeneration. Arch Neurol 1972;27:453-455.
6. Gathak NR, Santoso RA, McKinney WM. Cerebellar degeneration following long-term phenytoin therapy. Neurology 1976;26:818-820.
7. McLain LW, Martain JT, Allen JH. Cerebellar degeneration due to chronic phenytein therapy. Ann Neurol 1980;7:18-23.
8. Dam M. Number of Purkinje cells in patients with grand mal epilepsy treated with diphenylhydantoin. Epilepsia 1970;11:375-186.
9. Ney GC, Lantos G, Barr WB, Schaul N. Cerebellar atrophy in patientes with long-term phenytoin exposure and epilepsy. Arch Neurol 1994;51:767-771.
10. Luef G, Chemelli A, Birbamer G, Aichnar F, Bauer G. Phenytoin overdosage and cerebellar atrophy in epileptic patients: clinical and MRI findings. Eur Neurol 1994;(Suppl 1):79-81.
11. Luef G, Burtscher J, Kremser C, et al. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages. Eur Neurol 1996;36:273-277.
12. Koller WC, Glatt SL, Perlik S, Huckman MS, Fox JH. Cerebellar atrophy demonstrated by computed tomography. Neurology 1981;31:405-412.
13. Kaneko S, Otani K, Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988;29:459-467.
14. Kiefer R, Knoth R, Anagnostopoulos J, Volk B. Cerebellar injury due to phenytoin: identification and evolution of Purkinje cell axonal swellings in deep cerebellar nuclei of mice. Acta Neuropathol (Berl) 1989;77:289-298.
15. Volk B, Kirchgassner N. Damage of Purkinje cell axons following chronic phenytoin administration: an animal model of distal axonopathy. Acta Neuropathol (Berl) 1985;67:67-74.